Following the announcement in December 2023 that the PrEPVacc study team was discontinuing vaccinations following a review that determined a minimal chance the vaccine candidates being tested could stop human immunodeficiency virus (HIV) acquisition, many were disappointed.
With an estimated 1.3 million people worldwide becoming infected with HIV annually, there is a tremendous unmet need for a preventive vaccine.
HIV Vaccine Research Rekindles in 2024
Women Have Greater Mortality With Alcohol-Related Liver Disease
Findings persist across steatotic liver disease phenotypes
Concerns Associated With Elective Surgery Identified in Older U.S. Adults
64.3 percent reported being concerned about pain or discomfort; many adults also concerned about financial aspects
Pandemic Tied to Worsening of Diabetes Outcomes
Negative outcomes particularly seen for children and adolescents, including increase in diabetes-related admissions to pediatric ICUs, diabetic ketoacidosis